Loading clinical trials...
Loading clinical trials...
A Phase II Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer Previously Treated With Fluoropyrimidine-based Chemotherapy
Conditions
Interventions
Ixabepilone
Locations
9
Hong Kong
Local Institution
Hong Kong, Hong Kong
Local Institution
Nagoya, Aichi-ken, Japan
Local Institution
Sunto-Gun, Shizuoka, Japan
Local Institution
Singapore, Singapore
Local Institution
Seoul, South Korea
Local Institution
Seoul, South Korea
Start Date
November 1, 2009
Primary Completion Date
June 1, 2011
Completion Date
June 1, 2011
Last Updated
October 28, 2020
NCT06885697
NCT06630130
NCT07035587
NCT01649271
NCT02310230
NCT06260150
Lead Sponsor
R-Pharm
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions